Intercept Pharmaceuticals, Inc.
(NASDAQ GS: ICPT)
Rigrodsky Law, P.A. is investigating Intercept Pharmaceuticals, Inc. (“Intercept”) regarding possible breaches of fiduciary duties and other violations of law related to Intercept’s agreement to be acquired by Alfasigma S.p.A. Under the terms of the agreement, Intercept shareholders will receive $19.00 per share in cash.